

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.46797390 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.46797390 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.15438868 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.15438868 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.63050024 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.08396271 |
| 7 | tryptophan catabolic process (GO:0006569) | 5.90088356 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.90088356 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.90088356 |
| 10 | bile acid biosynthetic process (GO:0006699) | 5.77506292 |
| 11 | glyoxylate metabolic process (GO:0046487) | 5.75170928 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.69470293 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.58204734 |
| 14 | high-density lipoprotein particle remodeling (GO:0034375) | 5.41105756 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.39651815 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 5.34183172 |
| 17 | urea cycle (GO:0000050) | 5.28648588 |
| 18 | urea metabolic process (GO:0019627) | 5.28648588 |
| 19 | cysteine metabolic process (GO:0006534) | 5.24925480 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.19910268 |
| 21 | protein carboxylation (GO:0018214) | 5.09141335 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.09141335 |
| 23 | complement activation, alternative pathway (GO:0006957) | 5.05870735 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.04448105 |
| 25 | regulation of protein activation cascade (GO:2000257) | 4.94285572 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 4.93477597 |
| 27 | bile acid metabolic process (GO:0008206) | 4.90951847 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 4.90011057 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.88108439 |
| 30 | aromatic amino acid family metabolic process (GO:0009072) | 4.84613879 |
| 31 | regulation of cholesterol esterification (GO:0010872) | 4.77631961 |
| 32 | regulation of triglyceride catabolic process (GO:0010896) | 4.75411239 |
| 33 | reverse cholesterol transport (GO:0043691) | 4.72298516 |
| 34 | tyrosine metabolic process (GO:0006570) | 4.70667184 |
| 35 | plasma lipoprotein particle remodeling (GO:0034369) | 4.64019206 |
| 36 | protein-lipid complex remodeling (GO:0034368) | 4.64019206 |
| 37 | macromolecular complex remodeling (GO:0034367) | 4.64019206 |
| 38 | regulation of complement activation (GO:0030449) | 4.62333163 |
| 39 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.59674005 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.58188587 |
| 41 | alpha-amino acid catabolic process (GO:1901606) | 4.52421620 |
| 42 | acylglycerol homeostasis (GO:0055090) | 4.48689961 |
| 43 | triglyceride homeostasis (GO:0070328) | 4.48689961 |
| 44 | lysine catabolic process (GO:0006554) | 4.48536092 |
| 45 | lysine metabolic process (GO:0006553) | 4.48536092 |
| 46 | amino-acid betaine metabolic process (GO:0006577) | 4.48221357 |
| 47 | phospholipid efflux (GO:0033700) | 4.41564474 |
| 48 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.41285020 |
| 49 | coenzyme catabolic process (GO:0009109) | 4.39523710 |
| 50 | cellular ketone body metabolic process (GO:0046950) | 4.38657025 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 4.36797601 |
| 52 | negative regulation of sterol transport (GO:0032372) | 4.36797601 |
| 53 | plasma lipoprotein particle clearance (GO:0034381) | 4.34809888 |
| 54 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.32665932 |
| 55 | protein maturation by protein folding (GO:0022417) | 4.32259099 |
| 56 | cellular glucuronidation (GO:0052695) | 4.25387858 |
| 57 | respiratory electron transport chain (GO:0022904) | 4.23116116 |
| 58 | indolalkylamine metabolic process (GO:0006586) | 4.22844779 |
| 59 | cellular amino acid catabolic process (GO:0009063) | 4.20763989 |
| 60 | aldehyde catabolic process (GO:0046185) | 4.19578870 |
| 61 | electron transport chain (GO:0022900) | 4.18141069 |
| 62 | cellular biogenic amine catabolic process (GO:0042402) | 4.17061381 |
| 63 | amine catabolic process (GO:0009310) | 4.17061381 |
| 64 | glycine metabolic process (GO:0006544) | 4.14059151 |
| 65 | bile acid and bile salt transport (GO:0015721) | 4.11880105 |
| 66 | benzene-containing compound metabolic process (GO:0042537) | 4.10863182 |
| 67 | ethanol oxidation (GO:0006069) | 4.09723686 |
| 68 | serine family amino acid metabolic process (GO:0009069) | 4.07902569 |
| 69 | cholesterol efflux (GO:0033344) | 4.07126426 |
| 70 | imidazole-containing compound metabolic process (GO:0052803) | 4.06164848 |
| 71 | glutamate metabolic process (GO:0006536) | 4.01766441 |
| 72 | chaperone-mediated protein transport (GO:0072321) | 4.01635878 |
| 73 | GDP-mannose metabolic process (GO:0019673) | 3.97185070 |
| 74 | cellular modified amino acid catabolic process (GO:0042219) | 3.96867738 |
| 75 | protein complex biogenesis (GO:0070271) | 3.96410234 |
| 76 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.94755351 |
| 77 | ATP synthesis coupled proton transport (GO:0015986) | 3.94755351 |
| 78 | serine family amino acid biosynthetic process (GO:0009070) | 3.93545098 |
| 79 | low-density lipoprotein particle remodeling (GO:0034374) | 3.90860981 |
| 80 | arginine metabolic process (GO:0006525) | 3.88140076 |
| 81 | glucuronate metabolic process (GO:0019585) | 3.87293580 |
| 82 | uronic acid metabolic process (GO:0006063) | 3.87293580 |
| 83 | short-chain fatty acid metabolic process (GO:0046459) | 3.87278530 |
| 84 | cofactor catabolic process (GO:0051187) | 3.86566391 |
| 85 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.85154967 |
| 86 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.85154967 |
| 87 | drug catabolic process (GO:0042737) | 3.84655518 |
| 88 | plasma lipoprotein particle assembly (GO:0034377) | 3.80346167 |
| 89 | ketone body metabolic process (GO:1902224) | 3.80221104 |
| 90 | fibrinolysis (GO:0042730) | 3.78057262 |
| 91 | carboxylic acid catabolic process (GO:0046395) | 3.77835362 |
| 92 | organic acid catabolic process (GO:0016054) | 3.77835362 |
| 93 | negative regulation of lipase activity (GO:0060192) | 3.75184628 |
| 94 | acetyl-CoA metabolic process (GO:0006084) | 3.73879622 |
| 95 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.68226771 |
| 96 | blood coagulation, intrinsic pathway (GO:0007597) | 3.67701103 |
| 97 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.66512482 |
| 98 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.64750218 |
| 99 | cholesterol homeostasis (GO:0042632) | 3.62124747 |
| 100 | regulation of mitochondrial translation (GO:0070129) | 3.61672543 |
| 101 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.61662134 |
| 102 | positive regulation of lipid catabolic process (GO:0050996) | 3.60194082 |
| 103 | GTP biosynthetic process (GO:0006183) | 3.59677046 |
| 104 | proteasome assembly (GO:0043248) | 3.58626045 |
| 105 | response to nitrosative stress (GO:0051409) | 3.57558536 |
| 106 | monocarboxylic acid catabolic process (GO:0072329) | 3.57537285 |
| 107 | sterol homeostasis (GO:0055092) | 3.55820097 |
| 108 | fatty acid beta-oxidation (GO:0006635) | 3.55066668 |
| 109 | metallo-sulfur cluster assembly (GO:0031163) | 3.54669330 |
| 110 | iron-sulfur cluster assembly (GO:0016226) | 3.54669330 |
| 111 | fatty acid oxidation (GO:0019395) | 3.54154859 |
| 112 | complement activation, classical pathway (GO:0006958) | 3.52827533 |
| 113 | NAD biosynthetic process (GO:0009435) | 3.52689008 |
| 114 | plasma lipoprotein particle organization (GO:0071827) | 3.52585248 |
| 115 | protein activation cascade (GO:0072376) | 3.52558964 |
| 116 | flavonoid metabolic process (GO:0009812) | 3.51881000 |
| 117 | cytochrome complex assembly (GO:0017004) | 3.51774980 |
| 118 | complement activation (GO:0006956) | 3.51730830 |
| 119 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.50758041 |
| 120 | respiratory chain complex IV assembly (GO:0008535) | 3.49335438 |
| 121 | NADH metabolic process (GO:0006734) | 3.38573039 |
| 122 | nucleotide salvage (GO:0043173) | 3.37445538 |
| 123 | branched-chain amino acid catabolic process (GO:0009083) | 3.36155750 |
| 124 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.34583400 |
| 125 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.34517657 |
| 126 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.33475943 |
| 127 | NADH dehydrogenase complex assembly (GO:0010257) | 3.33475943 |
| 128 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.33475943 |
| 129 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.32826351 |
| 130 | base-excision repair, AP site formation (GO:0006285) | 3.31083771 |
| 131 | deoxyribonucleotide catabolic process (GO:0009264) | 3.30916374 |
| 132 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.29403799 |
| 133 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.24869572 |
| 134 | oxidative phosphorylation (GO:0006119) | 3.20735967 |
| 135 | pentose metabolic process (GO:0019321) | 3.18036256 |
| 136 | UTP biosynthetic process (GO:0006228) | 3.14559594 |
| 137 | protein targeting to mitochondrion (GO:0006626) | 3.11812030 |
| 138 | purine nucleotide salvage (GO:0032261) | 3.09310999 |
| 139 | mannosylation (GO:0097502) | 3.07826587 |
| 140 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.05593064 |
| 141 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.05593064 |
| 142 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.03955755 |
| 143 | deoxyribose phosphate catabolic process (GO:0046386) | 3.03531670 |
| 144 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.02088492 |
| 145 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.97445760 |
| 146 | regulation of cellular amine metabolic process (GO:0033238) | 2.96593803 |
| 147 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.93951984 |
| 148 | CTP biosynthetic process (GO:0006241) | 2.93529754 |
| 149 | CTP metabolic process (GO:0046036) | 2.93529754 |
| 150 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.91503453 |
| 151 | xenobiotic catabolic process (GO:0042178) | 2.90496695 |
| 152 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.87467443 |
| 153 | nucleoside salvage (GO:0043174) | 2.87082054 |
| 154 | UTP metabolic process (GO:0046051) | 2.86393581 |
| 155 | oxaloacetate metabolic process (GO:0006107) | 2.84490964 |
| 156 | establishment of protein localization to mitochondrion (GO:0072655) | 2.84169494 |
| 157 | hydrogen ion transmembrane transport (GO:1902600) | 2.83780041 |
| 158 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.82452507 |
| 159 | branched-chain amino acid metabolic process (GO:0009081) | 2.82099142 |
| 160 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.80419154 |
| 161 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.78896713 |
| 162 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.78896713 |
| 163 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.78078878 |
| 164 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.77392761 |
| 165 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.77279951 |
| 166 | negative regulation of ligase activity (GO:0051352) | 2.77279951 |
| 167 | amyloid precursor protein catabolic process (GO:0042987) | 2.76790631 |
| 168 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.75758191 |
| 169 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.75014948 |
| 170 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.75014948 |
| 171 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.75014948 |
| 172 | ubiquinone biosynthetic process (GO:0006744) | 2.73981174 |
| 173 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.73921689 |
| 174 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.73921689 |
| 175 | polyketide metabolic process (GO:0030638) | 2.73821735 |
| 176 | doxorubicin metabolic process (GO:0044598) | 2.73821735 |
| 177 | daunorubicin metabolic process (GO:0044597) | 2.73821735 |
| 178 | pyrimidine-containing compound salvage (GO:0008655) | 2.73430624 |
| 179 | pyrimidine nucleoside salvage (GO:0043097) | 2.73430624 |
| 180 | ATP biosynthetic process (GO:0006754) | 2.73196701 |
| 181 | heme metabolic process (GO:0042168) | 2.71441051 |
| 182 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.70439832 |
| 183 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.69923906 |
| 184 | protein localization to mitochondrion (GO:0070585) | 2.69427035 |
| 185 | L-serine metabolic process (GO:0006563) | 2.69291186 |
| 186 | deoxyribose phosphate metabolic process (GO:0019692) | 2.66849441 |
| 187 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.66319322 |
| 188 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.66319322 |
| 189 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.64619777 |
| 190 | autophagic vacuole fusion (GO:0000046) | 2.63995897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.08064628 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.90577529 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.83050091 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.22877178 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.30585034 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.14747731 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.03456756 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.24808365 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.96409238 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.88471219 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.74171893 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.37789088 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.94129782 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.69566420 |
| 15 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.56492646 |
| 16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.45235459 |
| 17 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.32498949 |
| 18 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.32130414 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.25784880 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.14613061 |
| 21 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.12433306 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.05975701 |
| 23 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.01032070 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.5646900 |
| 25 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.99334418 |
| 26 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.99051649 |
| 27 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.98666162 |
| 28 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.93957291 |
| 29 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.91229349 |
| 30 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.82283537 |
| 31 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.81058729 |
| 32 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.77446876 |
| 33 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.75884784 |
| 34 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.72665066 |
| 35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.69048771 |
| 36 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.65147249 |
| 37 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64818295 |
| 38 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.60431831 |
| 39 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.60112295 |
| 40 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.58085943 |
| 41 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.56856975 |
| 42 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.55829663 |
| 43 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.53265701 |
| 44 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.52535945 |
| 45 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51769187 |
| 46 | * P68_20966046_ChIP-Seq_HELA_Human | 1.51740428 |
| 47 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.50577906 |
| 48 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.48098424 |
| 49 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.48022866 |
| 50 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.47743181 |
| 51 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.46066823 |
| 52 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.45087947 |
| 53 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.45082565 |
| 54 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.44883296 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44847692 |
| 56 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44843210 |
| 57 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.40172126 |
| 58 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.35643339 |
| 59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35569300 |
| 60 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.33843548 |
| 61 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.33325954 |
| 62 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.32575606 |
| 63 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.32350351 |
| 64 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.31496675 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30234519 |
| 66 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.29117279 |
| 67 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.25900034 |
| 68 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25281017 |
| 69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22806091 |
| 70 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.20614917 |
| 71 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19810195 |
| 72 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.19451841 |
| 73 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.18814393 |
| 74 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.17191186 |
| 75 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.17121650 |
| 76 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.16634122 |
| 77 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.16316295 |
| 78 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.15271339 |
| 79 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.14473025 |
| 80 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.12858954 |
| 81 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.10676152 |
| 82 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08602677 |
| 83 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07881840 |
| 84 | SA1_27219007_Chip-Seq_Bcells_Human | 1.07369131 |
| 85 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06312937 |
| 86 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06163251 |
| 87 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05963313 |
| 88 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.01943225 |
| 89 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01864919 |
| 90 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.00946496 |
| 91 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.00714095 |
| 92 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.00656013 |
| 93 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.00537184 |
| 94 | * P300_27268052_Chip-Seq_Bcells_Human | 0.99023767 |
| 95 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.98646551 |
| 96 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97775609 |
| 97 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97237634 |
| 98 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97079798 |
| 99 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.96854940 |
| 100 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.95650386 |
| 101 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95153932 |
| 102 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90250740 |
| 103 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.87195221 |
| 104 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86281874 |
| 105 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84740506 |
| 106 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83926836 |
| 107 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.82106126 |
| 108 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.81560228 |
| 109 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.81427186 |
| 110 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.77388870 |
| 111 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.75105531 |
| 112 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.73042404 |
| 113 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72140606 |
| 114 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72140606 |
| 115 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71218771 |
| 116 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71192602 |
| 117 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.70148469 |
| 118 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.69009844 |
| 119 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68489222 |
| 120 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66218258 |
| 121 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66092891 |
| 122 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.65450905 |
| 123 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.65203522 |
| 124 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64644027 |
| 125 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64368877 |
| 126 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.63171416 |
| 127 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.62809375 |
| 128 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.62779149 |
| 129 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.62383272 |
| 130 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60104129 |
| 131 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.58356117 |
| 132 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.56988264 |
| 133 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.56323477 |
| 134 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.55466090 |
| 135 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.55289037 |
| 136 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.54592047 |
| 137 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54238654 |
| 138 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.53679864 |
| 139 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53496509 |
| 140 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.53105651 |
| 141 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.52614997 |
| 142 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.51825390 |
| 143 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51145614 |
| 144 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.50574711 |
| 145 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.49854381 |
| 146 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.49468608 |
| 147 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49458532 |
| 148 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.49098599 |
| 149 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.48428094 |
| 150 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48386296 |
| 151 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.43386495 |
| 152 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.43148880 |
| 153 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.42716378 |
| 154 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.42630982 |
| 155 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.42580472 |
| 156 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.42232638 |
| 157 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.41063690 |
| 158 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.40878688 |
| 159 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.40699978 |
| 160 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.40616026 |
| 161 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40229260 |
| 162 | GATA1_19941826_ChIP-Seq_K562_Human | 0.40047698 |
| 163 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.39952461 |
| 164 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39627883 |
| 165 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.39204575 |
| 166 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.38816478 |
| 167 | NCOR_22424771_ChIP-Seq_293T_Human | 0.38614792 |
| 168 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.38225626 |
| 169 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.37794155 |
| 170 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.37674487 |
| 171 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.37645592 |
| 172 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.37589054 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.14640392 |
| 2 | MP0005360_urolithiasis | 7.31817940 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.22308737 |
| 4 | MP0005365_abnormal_bile_salt | 6.00615623 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.13768752 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.31129471 |
| 7 | MP0003252_abnormal_bile_duct | 3.72897850 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.52874027 |
| 9 | MP0009840_abnormal_foam_cell | 3.26671188 |
| 10 | MP0005083_abnormal_biliary_tract | 3.00648340 |
| 11 | MP0005332_abnormal_amino_acid | 2.91676497 |
| 12 | MP0003195_calcinosis | 2.90708118 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.58379316 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.42214105 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.20588992 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.15218403 |
| 17 | MP0002653_abnormal_ependyma_morphology | 2.08867811 |
| 18 | MP0000609_abnormal_liver_physiology | 2.07079662 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.87321133 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.87102438 |
| 21 | MP0003868_abnormal_feces_composition | 1.78174179 |
| 22 | MP0001764_abnormal_homeostasis | 1.78101313 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.67546601 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.67293977 |
| 25 | MP0001905_abnormal_dopamine_level | 1.66999285 |
| 26 | MP0009697_abnormal_copulation | 1.59462579 |
| 27 | MP0003186_abnormal_redox_activity | 1.59455949 |
| 28 | MP0005451_abnormal_body_composition | 1.59133816 |
| 29 | MP0003011_delayed_dark_adaptation | 1.53158012 |
| 30 | MP0003123_paternal_imprinting | 1.40523654 |
| 31 | MP0000681_abnormal_thyroid_gland | 1.39071030 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.38255863 |
| 33 | MP0005410_abnormal_fertilization | 1.37311992 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.37149017 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.34173952 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.30575676 |
| 37 | MP0003878_abnormal_ear_physiology | 1.27670104 |
| 38 | MP0005377_hearing/vestibular/ear_phenot | 1.27670104 |
| 39 | MP0010386_abnormal_urinary_bladder | 1.26991705 |
| 40 | MP0002736_abnormal_nociception_after | 1.20818837 |
| 41 | MP0001968_abnormal_touch/_nociception | 1.20601285 |
| 42 | MP0005647_abnormal_sex_gland | 1.15358937 |
| 43 | MP0008260_abnormal_autophagy | 1.14897930 |
| 44 | MP0000598_abnormal_liver_morphology | 1.12551763 |
| 45 | MP0003879_abnormal_hair_cell | 1.12274633 |
| 46 | MP0005075_abnormal_melanosome_morpholog | 1.11140005 |
| 47 | MP0000372_irregular_coat_pigmentation | 1.10504222 |
| 48 | MP0005165_increased_susceptibility_to | 1.09966976 |
| 49 | MP0002909_abnormal_adrenal_gland | 1.09943893 |
| 50 | MP0009764_decreased_sensitivity_to | 1.09743954 |
| 51 | MP0003786_premature_aging | 1.09212782 |
| 52 | MP0005636_abnormal_mineral_homeostasis | 1.06829195 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 1.06754071 |
| 54 | MP0000604_amyloidosis | 1.04250133 |
| 55 | MP0002254_reproductive_system_inflammat | 1.04235455 |
| 56 | MP0005330_cardiomyopathy | 1.03599378 |
| 57 | MP0009763_increased_sensitivity_to | 0.99154764 |
| 58 | MP0002876_abnormal_thyroid_physiology | 0.98647251 |
| 59 | MP0005670_abnormal_white_adipose | 0.98356506 |
| 60 | MP0000358_abnormal_cell_content/ | 0.96453606 |
| 61 | MP0005379_endocrine/exocrine_gland_phen | 0.96021427 |
| 62 | MP0005408_hypopigmentation | 0.95996847 |
| 63 | MP0008469_abnormal_protein_level | 0.93297056 |
| 64 | MP0002277_abnormal_respiratory_mucosa | 0.90683009 |
| 65 | MP0009642_abnormal_blood_homeostasis | 0.89696988 |
| 66 | MP0010368_abnormal_lymphatic_system | 0.89489374 |
| 67 | MP0003690_abnormal_glial_cell | 0.88891148 |
| 68 | MP0009785_altered_susceptibility_to | 0.86195877 |
| 69 | MP0000343_altered_response_to | 0.85710382 |
| 70 | MP0005376_homeostasis/metabolism_phenot | 0.84750451 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 0.83996362 |
| 72 | MP0002163_abnormal_gland_morphology | 0.82352310 |
| 73 | MP0005025_abnormal_response_to | 0.82065616 |
| 74 | MP0005084_abnormal_gallbladder_morpholo | 0.81240736 |
| 75 | MP0002078_abnormal_glucose_homeostasis | 0.79371023 |
| 76 | MP0002229_neurodegeneration | 0.79201360 |
| 77 | MP0004130_abnormal_muscle_cell | 0.79190816 |
| 78 | MP0009765_abnormal_xenobiotic_induced | 0.79173632 |
| 79 | MP0005535_abnormal_body_temperature | 0.78930430 |
| 80 | MP0002693_abnormal_pancreas_physiology | 0.78222469 |
| 81 | MP0000678_abnormal_parathyroid_gland | 0.76701996 |
| 82 | MP0003880_abnormal_central_pattern | 0.75464997 |
| 83 | MP0002971_abnormal_brown_adipose | 0.75342405 |
| 84 | MP0005220_abnormal_exocrine_pancreas | 0.74719054 |
| 85 | MP0003705_abnormal_hypodermis_morpholog | 0.72166957 |
| 86 | MP0005334_abnormal_fat_pad | 0.72106981 |
| 87 | MP0001756_abnormal_urination | 0.69940835 |
| 88 | MP0001881_abnormal_mammary_gland | 0.69689337 |
| 89 | MP0002332_abnormal_exercise_endurance | 0.68919318 |
| 90 | MP0005266_abnormal_metabolism | 0.68216160 |
| 91 | MP0001661_extended_life_span | 0.66718826 |
| 92 | MP0001727_abnormal_embryo_implantation | 0.65483630 |
| 93 | MP0003329_amyloid_beta_deposits | 0.64352198 |
| 94 | MP0003724_increased_susceptibility_to | 0.63528431 |
| 95 | MP0001873_stomach_inflammation | 0.63259537 |
| 96 | MP0006035_abnormal_mitochondrial_morpho | 0.62396848 |
| 97 | MP0000538_abnormal_urinary_bladder | 0.62319985 |
| 98 | MP0000639_abnormal_adrenal_gland | 0.61025746 |
| 99 | MP0002837_dystrophic_cardiac_calcinosis | 0.57189940 |
| 100 | MP0004782_abnormal_surfactant_physiolog | 0.55546262 |
| 101 | MP0002822_catalepsy | 0.53993787 |
| 102 | MP0002136_abnormal_kidney_physiology | 0.53327593 |
| 103 | MP0003638_abnormal_response/metabolism_ | 0.52567638 |
| 104 | MP0005448_abnormal_energy_balance | 0.52381185 |
| 105 | MP0005464_abnormal_platelet_physiology | 0.51533614 |
| 106 | MP0003075_altered_response_to | 0.48372322 |
| 107 | MP0005666_abnormal_adipose_tissue | 0.47701143 |
| 108 | MP0005058_abnormal_lysosome_morphology | 0.46641678 |
| 109 | MP0008874_decreased_physiological_sensi | 0.45326592 |
| 110 | MP0005395_other_phenotype | 0.45057729 |
| 111 | MP0000230_abnormal_systemic_arterial | 0.45030661 |
| 112 | MP0003953_abnormal_hormone_level | 0.44291066 |
| 113 | MP0008873_increased_physiological_sensi | 0.43989627 |
| 114 | MP0009053_abnormal_anal_canal | 0.43955354 |
| 115 | MP0004043_abnormal_pH_regulation | 0.42498763 |
| 116 | MP0008872_abnormal_physiological_respon | 0.41043734 |
| 117 | MP0003718_maternal_effect | 0.40220211 |
| 118 | MP0004381_abnormal_hair_follicle | 0.39732684 |
| 119 | MP0003436_decreased_susceptibility_to | 0.39447486 |
| 120 | MP0005166_decreased_susceptibility_to | 0.39141161 |
| 121 | MP0006082_CNS_inflammation | 0.38145320 |
| 122 | MP0002132_abnormal_respiratory_system | 0.37275957 |
| 123 | MP0002928_abnormal_bile_duct | 0.35465853 |
| 124 | MP0000249_abnormal_blood_vessel | 0.34162626 |
| 125 | MP0004883_abnormal_blood_vessel | 0.33041292 |
| 126 | MP0005164_abnormal_response_to | 0.32764463 |
| 127 | MP0002796_impaired_skin_barrier | 0.32458332 |
| 128 | MP0009115_abnormal_fat_cell | 0.32132346 |
| 129 | MP0004147_increased_porphyrin_level | 0.30987552 |
| 130 | MP0001853_heart_inflammation | 0.29995562 |
| 131 | MP0002168_other_aberrant_phenotype | 0.29817102 |
| 132 | MP0002970_abnormal_white_adipose | 0.29761753 |
| 133 | MP0001845_abnormal_inflammatory_respons | 0.29519871 |
| 134 | MP0001765_abnormal_ion_homeostasis | 0.29310273 |
| 135 | MP0002295_abnormal_pulmonary_circulatio | 0.28936745 |
| 136 | MP0002090_abnormal_vision | 0.27298965 |
| 137 | MP0005595_abnormal_vascular_smooth | 0.27078164 |
| 138 | MP0000579_abnormal_nail_morphology | 0.25800356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.40930915 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.93848553 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.83226406 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.29837815 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.24090602 |
| 6 | Xanthomatosis (HP:0000991) | 6.00125308 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.97696094 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.51576006 |
| 9 | Complement deficiency (HP:0004431) | 4.99523921 |
| 10 | Hepatocellular necrosis (HP:0001404) | 4.90892671 |
| 11 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.86454662 |
| 12 | Hepatic necrosis (HP:0002605) | 4.68918891 |
| 13 | Mitochondrial inheritance (HP:0001427) | 4.63726945 |
| 14 | Joint hemorrhage (HP:0005261) | 4.62513713 |
| 15 | Acute necrotizing encephalopathy (HP:0006965) | 4.59975978 |
| 16 | Hyperammonemia (HP:0001987) | 4.58286028 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.47834673 |
| 18 | Hyperglycinemia (HP:0002154) | 4.40638175 |
| 19 | Ketosis (HP:0001946) | 4.32751323 |
| 20 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.25728928 |
| 21 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.25728928 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.23268535 |
| 23 | Acute encephalopathy (HP:0006846) | 4.23020048 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.16492424 |
| 25 | Epidermoid cyst (HP:0200040) | 4.16148567 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.15543947 |
| 27 | Hyperglycinuria (HP:0003108) | 4.13466032 |
| 28 | Abnormality of the common coagulation pathway (HP:0010990) | 4.11760559 |
| 29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.10796475 |
| 30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.10519240 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.07737778 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 4.07737778 |
| 33 | Fat malabsorption (HP:0002630) | 4.01156508 |
| 34 | Increased CSF lactate (HP:0002490) | 3.97494044 |
| 35 | Hypoalphalipoproteinemia (HP:0003233) | 3.93506859 |
| 36 | Increased intramyocellular lipid droplets (HP:0012240) | 3.92840248 |
| 37 | Hypoglycemic coma (HP:0001325) | 3.92137984 |
| 38 | Progressive macrocephaly (HP:0004481) | 3.75679868 |
| 39 | Increased muscle lipid content (HP:0009058) | 3.72444612 |
| 40 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.66332270 |
| 41 | Abnormality of the intrinsic pathway (HP:0010989) | 3.64033815 |
| 42 | Abnormality of complement system (HP:0005339) | 3.62323785 |
| 43 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.61184965 |
| 44 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.54672941 |
| 45 | Conjugated hyperbilirubinemia (HP:0002908) | 3.48374853 |
| 46 | Hypercholesterolemia (HP:0003124) | 3.42320716 |
| 47 | Prolonged neonatal jaundice (HP:0006579) | 3.41610715 |
| 48 | Hyperbilirubinemia (HP:0002904) | 3.26185670 |
| 49 | Lactic acidosis (HP:0003128) | 3.24776165 |
| 50 | Ketoacidosis (HP:0001993) | 3.20034879 |
| 51 | Steatorrhea (HP:0002570) | 3.16215872 |
| 52 | Delayed CNS myelination (HP:0002188) | 3.14769913 |
| 53 | Abnormality of serum amino acid levels (HP:0003112) | 3.13715280 |
| 54 | Renal Fanconi syndrome (HP:0001994) | 3.08227758 |
| 55 | Respiratory failure (HP:0002878) | 3.08176042 |
| 56 | Abnormality of glycolipid metabolism (HP:0010969) | 3.05442917 |
| 57 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.05442917 |
| 58 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.05442917 |
| 59 | Abnormality of nucleobase metabolism (HP:0010932) | 3.02349724 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.98443991 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.98443991 |
| 62 | Type I transferrin isoform profile (HP:0003642) | 2.95187366 |
| 63 | Exercise intolerance (HP:0003546) | 2.92228140 |
| 64 | Ragged-red muscle fibers (HP:0003200) | 2.88370153 |
| 65 | Metabolic acidosis (HP:0001942) | 2.88337242 |
| 66 | Lethargy (HP:0001254) | 2.86052897 |
| 67 | Increased serum lactate (HP:0002151) | 2.85323045 |
| 68 | Lipid accumulation in hepatocytes (HP:0006561) | 2.85272521 |
| 69 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.84895369 |
| 70 | Increased hepatocellular lipid droplets (HP:0006565) | 2.83425168 |
| 71 | Hepatocellular carcinoma (HP:0001402) | 2.77789606 |
| 72 | Cerebral edema (HP:0002181) | 2.76656806 |
| 73 | Spontaneous abortion (HP:0005268) | 2.75259922 |
| 74 | Abnormality of purine metabolism (HP:0004352) | 2.72932103 |
| 75 | Systemic lupus erythematosus (HP:0002725) | 2.69987866 |
| 76 | Vascular calcification (HP:0004934) | 2.67982191 |
| 77 | Vacuolated lymphocytes (HP:0001922) | 2.66915042 |
| 78 | Myocardial infarction (HP:0001658) | 2.63682438 |
| 79 | Skin nodule (HP:0200036) | 2.62047681 |
| 80 | Abnormality of glycolysis (HP:0004366) | 2.58989708 |
| 81 | Emotional lability (HP:0000712) | 2.58291908 |
| 82 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.57730872 |
| 83 | Increased serum pyruvate (HP:0003542) | 2.55299776 |
| 84 | Gout (HP:0001997) | 2.55148381 |
| 85 | Generalized aminoaciduria (HP:0002909) | 2.50018180 |
| 86 | CNS demyelination (HP:0007305) | 2.48981038 |
| 87 | Hypochromic microcytic anemia (HP:0004840) | 2.45820131 |
| 88 | Testicular atrophy (HP:0000029) | 2.45586639 |
| 89 | Abnormal gallbladder morphology (HP:0012437) | 2.42386590 |
| 90 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.40942401 |
| 91 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.40942401 |
| 92 | Abnormal protein glycosylation (HP:0012346) | 2.40942401 |
| 93 | Abnormal glycosylation (HP:0012345) | 2.40942401 |
| 94 | Reduced antithrombin III activity (HP:0001976) | 2.39207583 |
| 95 | Myokymia (HP:0002411) | 2.38311749 |
| 96 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.36614679 |
| 97 | Cholecystitis (HP:0001082) | 2.36597163 |
| 98 | Abnormal gallbladder physiology (HP:0012438) | 2.36597163 |
| 99 | Hypoglycemic seizures (HP:0002173) | 2.35402205 |
| 100 | Cardiovascular calcification (HP:0011915) | 2.35311324 |
| 101 | Irritability (HP:0000737) | 2.35199734 |
| 102 | Cholelithiasis (HP:0001081) | 2.33707589 |
| 103 | Vomiting (HP:0002013) | 2.31782971 |
| 104 | Increased cerebral lipofuscin (HP:0011813) | 2.30684919 |
| 105 | Neonatal onset (HP:0003623) | 2.30382509 |
| 106 | Amyloidosis (HP:0011034) | 2.30297059 |
| 107 | Glomerulonephritis (HP:0000099) | 2.27514775 |
| 108 | Microretrognathia (HP:0000308) | 2.25615312 |
| 109 | Brushfield spots (HP:0001088) | 2.24636827 |
| 110 | Acanthocytosis (HP:0001927) | 2.24023900 |
| 111 | Microvesicular hepatic steatosis (HP:0001414) | 2.23036690 |
| 112 | Malnutrition (HP:0004395) | 2.22946340 |
| 113 | Pancreatitis (HP:0001733) | 2.21423788 |
| 114 | Spastic diplegia (HP:0001264) | 2.19993295 |
| 115 | Cerebral palsy (HP:0100021) | 2.19542240 |
| 116 | Mitral stenosis (HP:0001718) | 2.19042264 |
| 117 | Progressive microcephaly (HP:0000253) | 2.18057372 |
| 118 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.17996334 |
| 119 | Opisthotonus (HP:0002179) | 2.16461713 |
| 120 | Late onset (HP:0003584) | 2.15914119 |
| 121 | Sensorimotor neuropathy (HP:0007141) | 2.15046784 |
| 122 | Progressive neurologic deterioration (HP:0002344) | 2.14581857 |
| 123 | Loss of speech (HP:0002371) | 2.12522931 |
| 124 | Hypokinesia (HP:0002375) | 2.09477879 |
| 125 | Dysostosis multiplex (HP:0000943) | 2.09360763 |
| 126 | Enlarged kidneys (HP:0000105) | 2.08926393 |
| 127 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.08421590 |
| 128 | Proximal tubulopathy (HP:0000114) | 2.06725420 |
| 129 | Hyperthyroidism (HP:0000836) | 2.06069232 |
| 130 | Renal cortical cysts (HP:0000803) | 2.03810569 |
| 131 | Menorrhagia (HP:0000132) | 2.03235792 |
| 132 | J-shaped sella turcica (HP:0002680) | 2.02900101 |
| 133 | Alkalosis (HP:0001948) | 2.02567728 |
| 134 | Gingival bleeding (HP:0000225) | 2.02395122 |
| 135 | Abnormality of urine glucose concentration (HP:0011016) | 2.01203201 |
| 136 | Glycosuria (HP:0003076) | 2.01203201 |
| 137 | Abnormality of proline metabolism (HP:0010907) | 1.99771139 |
| 138 | Hydroxyprolinuria (HP:0003080) | 1.99771139 |
| 139 | Leukodystrophy (HP:0002415) | 1.99341557 |
| 140 | Hyperphosphaturia (HP:0003109) | 1.97426873 |
| 141 | Abnormality of the gallbladder (HP:0005264) | 1.97060509 |
| 142 | Esophageal varix (HP:0002040) | 1.95915860 |
| 143 | Exertional dyspnea (HP:0002875) | 1.95429530 |
| 144 | Rhabdomyolysis (HP:0003201) | 1.95286639 |
| 145 | Hemorrhage of the eye (HP:0011885) | 1.95284371 |
| 146 | 3-Methylglutaconic aciduria (HP:0003535) | 1.95107811 |
| 147 | Rickets (HP:0002748) | 1.95021542 |
| 148 | Degeneration of anterior horn cells (HP:0002398) | 1.94463647 |
| 149 | Abnormality of the anterior horn cell (HP:0006802) | 1.94463647 |
| 150 | Thrombophlebitis (HP:0004418) | 1.91666399 |
| 151 | Optic disc pallor (HP:0000543) | 1.91293260 |
| 152 | Methylmalonic aciduria (HP:0012120) | 1.91131881 |
| 153 | Elevated hepatic transaminases (HP:0002910) | 1.91113067 |
| 154 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.90219615 |
| 155 | Increased serum ferritin (HP:0003281) | 1.89784635 |
| 156 | Abnormality of vitamin metabolism (HP:0100508) | 1.89635275 |
| 157 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.89065242 |
| 158 | Progressive muscle weakness (HP:0003323) | 1.86038563 |
| 159 | Petechiae (HP:0000967) | 1.85101234 |
| 160 | Hypophosphatemic rickets (HP:0004912) | 1.84454574 |
| 161 | Abnormal cartilage morphology (HP:0002763) | 1.84066974 |
| 162 | Abnormality of iron homeostasis (HP:0011031) | 1.82011260 |
| 163 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81918915 |
| 164 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.79795985 |
| 165 | Gliosis (HP:0002171) | 1.79689333 |
| 166 | Nausea (HP:0002018) | 1.77633902 |
| 167 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.76849329 |
| 168 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.76849329 |
| 169 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.76849329 |
| 170 | Cerebral hypomyelination (HP:0006808) | 1.76421460 |
| 171 | Hepatosplenomegaly (HP:0001433) | 1.74351125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.91846780 |
| 2 | VRK2 | 5.24308047 |
| 3 | ERN1 | 4.09745627 |
| 4 | SIK1 | 3.96040353 |
| 5 | FGFR4 | 3.94637264 |
| 6 | TESK1 | 3.54361341 |
| 7 | TESK2 | 3.37446811 |
| 8 | INSRR | 3.12579906 |
| 9 | PIM2 | 2.87933835 |
| 10 | TAOK3 | 2.70186335 |
| 11 | MAPKAPK3 | 2.61014542 |
| 12 | ARAF | 2.41895224 |
| 13 | ERBB4 | 2.39571752 |
| 14 | LIMK1 | 2.24843356 |
| 15 | MST1R | 2.20101642 |
| 16 | EPHA2 | 2.02014606 |
| 17 | SCYL2 | 1.96187078 |
| 18 | MAP2K4 | 1.86100982 |
| 19 | FLT3 | 1.84005009 |
| 20 | PIK3CG | 1.77291967 |
| 21 | ABL2 | 1.75503621 |
| 22 | DAPK1 | 1.75195365 |
| 23 | MAP3K12 | 1.66957129 |
| 24 | PINK1 | 1.65700164 |
| 25 | MUSK | 1.64377837 |
| 26 | MAP4K2 | 1.57612926 |
| 27 | MAPK11 | 1.56948724 |
| 28 | MAP2K3 | 1.54472368 |
| 29 | LATS1 | 1.54219597 |
| 30 | NME1 | 1.52813997 |
| 31 | TYK2 | 1.52305041 |
| 32 | MAP3K3 | 1.46888824 |
| 33 | PKN2 | 1.46259745 |
| 34 | TIE1 | 1.45017197 |
| 35 | TRIB3 | 1.39508336 |
| 36 | NEK9 | 1.30924347 |
| 37 | KDR | 1.28267130 |
| 38 | MAPK15 | 1.26917048 |
| 39 | EPHB1 | 1.25108938 |
| 40 | DAPK2 | 1.18289446 |
| 41 | FRK | 1.16929291 |
| 42 | PRKAA2 | 1.14835208 |
| 43 | LMTK2 | 1.09341847 |
| 44 | PTK6 | 1.06452214 |
| 45 | TBK1 | 1.05066716 |
| 46 | RPS6KB2 | 1.04361931 |
| 47 | SMG1 | 1.02238188 |
| 48 | MAP3K7 | 1.02061455 |
| 49 | TNK2 | 1.00667225 |
| 50 | JAK2 | 0.99589884 |
| 51 | IRAK3 | 0.99206653 |
| 52 | MET | 0.96877911 |
| 53 | STK38L | 0.94895024 |
| 54 | LRRK2 | 0.94365283 |
| 55 | PRKCI | 0.94291964 |
| 56 | MAP3K14 | 0.93981970 |
| 57 | VRK1 | 0.92735273 |
| 58 | MAPK4 | 0.91183138 |
| 59 | EPHA3 | 0.91168618 |
| 60 | FGFR2 | 0.90617557 |
| 61 | ILK | 0.88311946 |
| 62 | DAPK3 | 0.86726596 |
| 63 | CSNK1A1L | 0.85960859 |
| 64 | IKBKB | 0.83504273 |
| 65 | PBK | 0.82484245 |
| 66 | CAMK2G | 0.81589643 |
| 67 | PRKCZ | 0.80444432 |
| 68 | ERBB2 | 0.80292090 |
| 69 | MYLK | 0.79224439 |
| 70 | MAP3K11 | 0.79177959 |
| 71 | PHKG2 | 0.74225238 |
| 72 | PHKG1 | 0.74225238 |
| 73 | KIT | 0.72475373 |
| 74 | JAK1 | 0.71152111 |
| 75 | PRKACG | 0.70520311 |
| 76 | MAP4K1 | 0.70479844 |
| 77 | WNK4 | 0.69638436 |
| 78 | MAP2K6 | 0.69222436 |
| 79 | MAPK12 | 0.68379236 |
| 80 | GRK6 | 0.68237164 |
| 81 | PAK4 | 0.67305224 |
| 82 | CAMK2D | 0.66985477 |
| 83 | GRK5 | 0.66768654 |
| 84 | GSK3A | 0.66596441 |
| 85 | TGFBR2 | 0.65722964 |
| 86 | NUAK1 | 0.64108803 |
| 87 | NME2 | 0.63837601 |
| 88 | PDPK1 | 0.63309554 |
| 89 | SGK494 | 0.62885094 |
| 90 | SGK223 | 0.62885094 |
| 91 | GRK1 | 0.61829328 |
| 92 | AURKA | 0.59562635 |
| 93 | MAPKAPK5 | 0.59458623 |
| 94 | CAMK1D | 0.59344872 |
| 95 | IKBKE | 0.59219710 |
| 96 | STK16 | 0.58708852 |
| 97 | DYRK1B | 0.58226845 |
| 98 | STK39 | 0.57431363 |
| 99 | PKN1 | 0.57247641 |
| 100 | MST4 | 0.56549736 |
| 101 | PDK4 | 0.56325909 |
| 102 | PDK3 | 0.56325909 |
| 103 | CSNK1G1 | 0.56159282 |
| 104 | CSK | 0.55332801 |
| 105 | BUB1 | 0.54934320 |
| 106 | TAOK2 | 0.54775161 |
| 107 | PRKCQ | 0.54432468 |
| 108 | RPS6KA5 | 0.53944393 |
| 109 | IRAK1 | 0.53336514 |
| 110 | SGK3 | 0.52971806 |
| 111 | CSF1R | 0.52213437 |
| 112 | PRKAA1 | 0.51275866 |
| 113 | SGK2 | 0.50863953 |
| 114 | BRAF | 0.50174975 |
| 115 | OXSR1 | 0.50168266 |
| 116 | SRPK1 | 0.50079124 |
| 117 | PIK3CA | 0.48952277 |
| 118 | MAPK7 | 0.47253438 |
| 119 | EPHA4 | 0.46671859 |
| 120 | CDK19 | 0.45280838 |
| 121 | CSNK1G3 | 0.45203867 |
| 122 | MAP3K1 | 0.43730434 |
| 123 | MAP2K2 | 0.43167359 |
| 124 | TLK1 | 0.41684271 |
| 125 | MAP2K7 | 0.41090333 |
| 126 | IRAK2 | 0.39669840 |
| 127 | PRKD3 | 0.39461754 |
| 128 | MAP2K1 | 0.38748364 |
| 129 | CSNK2A1 | 0.38725747 |
| 130 | CAMK2B | 0.38607987 |
| 131 | CSNK1A1 | 0.38570744 |
| 132 | TAOK1 | 0.37697757 |
| 133 | IGF1R | 0.37410355 |
| 134 | DYRK2 | 0.36798452 |
| 135 | CDK6 | 0.36646573 |
| 136 | CSNK2A2 | 0.36579915 |
| 137 | EIF2AK1 | 0.35857300 |
| 138 | PAK1 | 0.35731779 |
| 139 | PAK6 | 0.33914302 |
| 140 | EPHB2 | 0.33162456 |
| 141 | CSNK1G2 | 0.33161075 |
| 142 | MAP3K6 | 0.31220580 |
| 143 | PRKCD | 0.30228265 |
| 144 | PRKCG | 0.30197574 |
| 145 | PRKD1 | 0.29824948 |
| 146 | MINK1 | 0.29681554 |
| 147 | SIK3 | 0.29677617 |
| 148 | CCNB1 | 0.29361667 |
| 149 | PRPF4B | 0.29326108 |
| 150 | PRKCA | 0.28792331 |
| 151 | PDK1 | 0.28429314 |
| 152 | FER | 0.26585916 |
| 153 | PRKACA | 0.26001446 |
| 154 | PTK2 | 0.25721403 |
| 155 | PDK2 | 0.25645709 |
| 156 | ADRBK2 | 0.25564549 |
| 157 | ICK | 0.25373294 |
| 158 | GRK7 | 0.25242913 |
| 159 | AKT2 | 0.23699208 |
| 160 | EGFR | 0.23645747 |
| 161 | CAMK4 | 0.22543827 |
| 162 | HIPK2 | 0.21227656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.30464634 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.49796064 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.30856104 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.08424975 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.01122044 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.81087933 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.74675958 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63410354 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62886691 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.56219004 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54478282 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.52758642 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.50359541 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.33684649 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 2.25090864 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.24099589 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.19737088 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.19604786 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.10723579 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.02577614 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.02009205 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.98541373 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92610017 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.88831957 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87999384 |
| 26 | Huntingtons disease_Homo sapiens_hsa05016 | 1.83613435 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.75524991 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73441283 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.72950161 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.72209757 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.70185237 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62440918 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.62182087 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61414872 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.60759783 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.57822723 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.56718446 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55263781 |
| 39 | Base excision repair_Homo sapiens_hsa03410 | 1.55208534 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.54803035 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52116702 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.51352451 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.49272392 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.48528999 |
| 45 | RNA polymerase_Homo sapiens_hsa03020 | 1.43461680 |
| 46 | Bile secretion_Homo sapiens_hsa04976 | 1.38561624 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.34747392 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32906205 |
| 49 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.31413296 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29621196 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28503093 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18275490 |
| 53 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.17496674 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16146683 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 1.14893966 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13410913 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13309506 |
| 58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.12664960 |
| 59 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.09398675 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 1.06803844 |
| 61 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.03741140 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00020429 |
| 63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.98036085 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96421016 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.94717986 |
| 66 | DNA replication_Homo sapiens_hsa03030 | 0.93969637 |
| 67 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.91607388 |
| 68 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90784813 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.87794822 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.84118765 |
| 71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.83431634 |
| 72 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.81843963 |
| 73 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81705000 |
| 74 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.81233141 |
| 75 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72829477 |
| 76 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71694994 |
| 77 | Homologous recombination_Homo sapiens_hsa03440 | 0.69125291 |
| 78 | Purine metabolism_Homo sapiens_hsa00230 | 0.67317620 |
| 79 | Lysine degradation_Homo sapiens_hsa00310 | 0.66552747 |
| 80 | Mismatch repair_Homo sapiens_hsa03430 | 0.64248463 |
| 81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64035689 |
| 82 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63511350 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60385112 |
| 84 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56503472 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56009029 |
| 86 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51237741 |
| 87 | Asthma_Homo sapiens_hsa05310 | 0.45531686 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45478742 |
| 89 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.45300997 |
| 90 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.42776902 |
| 91 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39099558 |
| 92 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37607709 |
| 93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35317013 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34329843 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.31213767 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.30954068 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30891053 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30669889 |
| 99 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.30495851 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29910351 |
| 101 | Mineral absorption_Homo sapiens_hsa04978 | 0.27598260 |
| 102 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.23857804 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20393005 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16209316 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.15351136 |
| 106 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.06473966 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.03106367 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.02502056 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.00276638 |
| 110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2155349 |
| 111 | Other glycan degradation_Homo sapiens_hsa00511 | -0.2090501 |
| 112 | Lysosome_Homo sapiens_hsa04142 | -0.1913760 |
| 113 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1908774 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | -0.1880889 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1751587 |
| 116 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1698190 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1600161 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1556058 |
| 119 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1405831 |
| 120 | Protein export_Homo sapiens_hsa03060 | -0.1173093 |
| 121 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0931473 |
| 122 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0790495 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0752720 |
| 124 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0680186 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0535044 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0371464 |
| 127 | Parkinsons disease_Homo sapiens_hsa05012 | -0.0315413 |

